|
Volumn 18, Issue 8, 2001, Pages 421-425
|
Cost-effectiveness of the use of spironolactone in the treatment of chronic heart failure;Análisis coste-efectividad del uso de espironolactona en el tratamiento de la insuficiencia cardiaca crónica
a a
a
Pharmacia SA
(Spain)
|
Author keywords
Chronic heart failure; Cost effectiveness analysis; Life years gained; Spironolactone
|
Indexed keywords
DIGOXIN;
DIURETIC AGENT;
DOBUTAMINE;
FUROSEMIDE;
SPIRONOLACTONE;
ARTICLE;
COHORT ANALYSIS;
CONTROLLED STUDY;
COST EFFECTIVENESS ANALYSIS;
DRUG COST;
DRUG EFFICACY;
HEART FAILURE;
HOSPITALIZATION;
HUMAN;
LIFESPAN;
MAJOR CLINICAL STUDY;
MORTALITY;
ALDOSTERONE ANTAGONISTS;
COST-BENEFIT ANALYSIS;
HEART FAILURE, CONGESTIVE;
HOSPITALIZATION;
HUMANS;
SPAIN;
SPIRONOLACTONE;
SURVIVAL ANALYSIS;
|
EID: 0034843153
PISSN: 02127199
EISSN: None
Source Type: Journal
DOI: None Document Type: Article |
Times cited : (4)
|
References (24)
|